Biomedical Catalyst Fund

Summary

The fund was located in Europe if to be more exact in United Kingdom. The main office of represented VC is situated in the Swindon.

Among the most successful fund investment fields, there are Health Care, Medical. Among the most popular portfolio startups of the fund, we may highlight Adaptimmune, Immunocore, MediSieve. The fund has exact preference in some founders of portfolio startups. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United Kingdom.

The higher amount of exits for fund were in 2015. The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of 1 - 5 millions dollars. Opposing the other organizations, this Biomedical Catalyst Fund works on 16 percentage points less the average amount of lead investments. The important activity for fund was in 2012. Despite it in 2019 the fund had an activity. Speaking about the real fund results, this VC is 30 percentage points more often commits exit comparing to other organizations.

The typical case for the fund is to invest in rounds with 1-2 participants. Despite the Biomedical Catalyst Fund, startups are often financed by Innovate UK, Unilever Ventures, Oxford Technology Management. The meaningful sponsors for the fund in investment in the same round are Sulis Innovation, SBRI Healthcare, Innovate UK. In the next rounds fund is usually obtained by Scottish Investment Bank, Innovate UK, DSM Venturing.